Using AI Agents and Bio-Foundation Models to Automate Vector Design for Cell Line Development

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 21 Oct, 18:14 UTC

In this GEN webinar, Asimov’s VP of Business Development and Commercial Strategy Jamie Freeman, PhD, will show how Asimov combines bio-foundation models, AI agents, and synthetic biology to tailor expression vector design for each molecule. The post Using AI Agents and Bio-Foundation Models to…

science

Sources

• T2Using AI Agents and Bio-Foundation Models to Automate Vector Design for Cell Line DevelopmentFierce Biotech / Fierce Healthcare / MedCity / GEN21 Oct, 18:14